首页> 外国专利> IMMUNE COMBINATION FOR INDUCING BROAD-SPECTRUM NEUTRALIZING ANTIBODY AGAINST HIV-1

IMMUNE COMBINATION FOR INDUCING BROAD-SPECTRUM NEUTRALIZING ANTIBODY AGAINST HIV-1

机译:免疫组合诱导抗HIV-1的广谱中和抗体

摘要

The present invention relates to the field of vaccines, and relates in particular to a vaccine combination for inducing a broad-spectrum neutralizing antibody against HIV-1. The form of a combined vaccine is employed, an HIV-1 membrane protein is used as an immunogen in a first injection; vaccine presentation forms comprise but are not limited to a recombinant plasmid vaccine, a recombinant protein subunit vaccine, a recombinant virus vector vaccine, a virus-like particle vaccine, a nanoparticle vaccine, an attenuated live vaccine and an inactivated virus vaccine; a second injection employs a virus vector vaccine for expressing an HIV-1 membrane protein, which can substantially improve the titer and broad spectrum properties of an induced anti-HIV-1 neutralizing antibody. The virus vector comprises but is not limited to poxvirus, adenovirus, herpes simplex virus, measles virus, enterovirus and rhabdovirus. A third injection and fourth injection are protein nanoparticle vaccine and virus vector vaccine combinations or vice versa. Inoculation modes of the vaccine comprise but are not limited to muscle inoculation, intracutaneous inoculation, subcutaneous inoculation, nasal drops, aerosol inhalation, the genital tract, the rectum, oral administration, and so on. The results of animal experiments prove that the vaccine combination is safe, can continuously generate a high-titer broad-spectrum neutralizing antibody, and can be used for preventing and treating AIDS in the future.
机译:本发明涉及疫苗领域,并且尤其涉及诱导抗HIV-1的广谱中和抗体的疫苗组合。使用组合疫苗的形式,在第一次注射中使用HIV-1膜蛋白作为免疫原;疫苗呈递形式包括但不限于重组质粒疫苗,重组蛋白亚基疫苗,重组病毒载体疫苗,病毒样颗粒疫苗,纳米颗粒疫苗,减毒的活疫苗和灭活病毒疫苗;第二注射使用病毒载体疫苗,用于表达HIV-1膜蛋白,其可以基本上改善诱导的抗HIV-1中和抗体的滴度和广谱性质。病毒载体包括但不限于痘病毒,腺病毒,单纯疱疹病毒,麻疹病毒,肠道病毒和rhabdovirus。第三次注射和第四注射是蛋白质纳米颗粒疫苗和病毒载体疫苗组合,反之亦然。疫苗的接种模式包括但不限于肌肉接种,皮内接种,皮下接种,鼻涕,气溶胶吸入,生殖器,直肠,口服给药等。动物实验的结果证明疫苗组合是安全的,可以连续产生高滴度宽谱中和抗体,可用于预防和治疗未来的艾滋病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号